Hamburg study tracks health and imaging to spot chronic diseases early
Follows adults aged 45 to 74 in Hamburg to learn early signs of chronic diseases.
Key facts
- Who runs it
- Universitätsklinikum Hamburg-Eppendorf
- Where
- Hamburg, GermanySee the site
- Trial code
- Registry title
- Hamburg City Health Study - a German Cohort Study
- Status
- Recruiting
- People taking part
- 45,000 people, planned
- Started
- 8 Feb 2016
- Expected to end
- 31 Dec 2028
- Type of study
- Observational
- Record updated
- 2 May 2019
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 45 to 74 who live in the city of Hamburg. It is a long-term health study of the general population.
- Age
- 45 to 74 years
- Sex
- All sexes can join.
Main reasons for not taking part
- Not enough knowledge of German to understand the study documents and the computer-assisted interview without translation
- Physically or mentally unable to travel to the study center and take part in the examinations
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Inhabitant of the city of Hamburg at the time of inclusion into the study (Inclusion is time of written consent)
- Age 45 to 74 years
- Personally signed informed consent
Who cannot take part
- Insufficient knowledge of the German language, in order to understand study documents and computer assisted interview without translation
- Physical or psychological incapability to travel to the study center and to cooperate in the investigations
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 45 and 74 years old?
Where in Germany
- Universitätsklinikum Hamburg-EppendorfHamburg, GermanyContact: Susannw BruderTaking people
About the trial
What the trial wants to find out
The Hamburg City Health Study (HCHS) is a large, prospective, long-term, population-based cohort study and a unique research platform and network to obtain substantial knowledge about several risk and prognostic factors in major chronic diseases.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Single Center, Prospective, Epidemiologic Cohort Study With Emphasis on Imaging to Improve the Identification of Individuals at Risk for Major Chronic Diseases and to Improve Early Diagnosis and Survival
- Plain-language title
- Hamburg study tracks health and imaging to spot chronic diseases earlyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT03934957, who can take part
- Publications
- Associations Between the Brain Care Score and Structural Brain Changes and Cognitive Impairment Using Data From the Hamburg City Health Study.European journal of neurology, 2026
- CMR-based aortic stiffness parameters in a symptomatic high risk obstructive sleep apnea cohort: results from the population-based Hamburg City Health Study.BMC cardiovascular disorders, 2026
- Association of periodontitis with reduced kidney function and albuminuria in early chronic kidney disease: a population-based study.International journal of oral science, 2026
- Amplified P-wave duration predicts incident atrial fibrillation in the general population: Results from the Hamburg City Health Study.Heart rhythm O2, 2026
- Biopsychosocial Correlates of Somatic Symptom Burden in CKD: Results of the Hamburg City Health Study.Kidney360, 2026
- Record updated
- 2 May 2019